NEW Nephros DkBlueRGB.png
Nephros to Participate in the Benchmark Company Annual Discovery One-on-One Investor Conference on December 11, 2024 in NYC
December 04, 2024 09:00 ET | Nephros, Inc.
SOUTH ORANGE, N.J., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today...
logo.png
Sacks Parente Golf, Inc. Announces Pricing of Initial Public Offering
August 15, 2023 08:00 ET | Sacks Parente Golf, Inc.
Camarillo, CA., Aug. 15, 2023 (GLOBE NEWSWIRE) -- Sacks Parente Golf, Inc. (NASDAQ:SPGC), (the Company), a technology-forward golf company, with a growing portfolio of golf products, including...
Logo.png
Biofrontera Inc. Pricing of $15 Million Private Placement Priced At-the-Market Under Nasdaq Rules
November 29, 2021 09:27 ET | Biofrontera Inc.
WOBURN, MA., Nov. 29, 2021 (GLOBE NEWSWIRE) -- Biofrontera, Inc. (Nasdaq: BFRI; BFRIW), today announced today that it has entered into a securities purchase agreement with a single institutional...
Logo.png
Processa Pharmaceuticals Announces Pricing of $19.2 Million Public Offering and Uplisting to the Nasdaq Capital Market
October 02, 2020 06:00 ET | Processa Pharmaceuticals, Inc.
HANOVER, MD, Oct. 02, 2020 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (OTCQB: PCSA; Nasdaq: PCSA), a clinical-stage biopharmaceutical company focused on the development of drug products that...
CLPS Incorporation A
CLPS Incorporation Announces Full Exercise of the Underwriters’ Over-Allotment Option for Its Full Commitment Initial Public Offering
June 15, 2018 11:01 ET | CLPS Incorporation
Shanghai, China, June 15, 2018 (GLOBE NEWSWIRE) -- CLPS Incorporation (the "Company" or Nasdaq: CLPS), a leading information technology consulting and solutions service provider focusing on the...